Figure 2.

Adherence to ARBs compared with ACE-Is: meta-analysis results. Hazard ratios and odds ratios with 95% CI on a logarithmic scale for individual or pooled study data for relative risk of adherence. Black boxes indicate studies in which adherence was measured as persistence; white box, study in which adherence was measured as compliance. Various adjustments were performed (Adapted from [Kronish et al. 2011]).

ACE-I, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; CI, confidence interval.